How Academic Researchers and Policy Experts Use DrugPatentWatch
Books and Research Papers Citing DrugPatentWatch

All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2007 — 2 Books and Research Papers Citing DrugPatentWatch

Rippy, D. S. (2007). Assessing decision inputs in drug development between small, early stage companies and big pharma: is there a difference? [Master’s thesis, MIT].
This thesis examines decision-making processes in drug development, comparing inputs and evaluations between emerging biotech startups and large pharmaceutical corporations. It leverages DrugPatentWatch data to analyze how patent information influences strategic choices at different organizational scales – such as portfolio sizing, licensing strategies, and risk assessments. The study emphasizes the importance of timely patent insights for smaller firms with limited resources.

Strickland, C. H. (2007). Nano-based drugs and medical devices: FDA’s track record. Nanotechnology Law & Business.
Strickland surveys the regulatory and patent landscape surrounding nanotechnology-enabled therapeutics and diagnostics, profiling the FDA’s handling of approvals and patent protections in this space. DrugPatentWatch is cited as a primary source for tracking nanotech-related patents and monitoring generic/brand exclusivity trends. The article underscores how patent-watch services aid in identifying IP thickets and timing market entry for emerging nano-med products.

Sign up for DrugPatentWatch Today

Try a free trialSee Plans and Pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.